Regional correlations between MR imaging perfusion and SPECT in Alzheimer's disease

Neurologia

Volumn 20, Issue 5, 2005, Pages 240-244

  Olazarán, Javier ^a,b,f   Alvarez Linera J ^c   De Santiago, R ^c   Escribano, J ^c   Benito Leon J ^d   Morales, J M ^e  

^a Neurology Clinic   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c International Ruber Hospital   (Spain)

^d HOSPITAL DE MÓSTOLES   (Spain)

^e Ministry of Social Affairs   (Spain)

^f NONE   (Spain)

Author keywords

Alzheimer's disease; Diagnosis; Dynamic susceptibility contrast; Perfusion magnetic resonance imaging; Single photon emission tomography

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; FEMALE; GREAT BLOOD VESSEL; HEAD MOVEMENT; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENEAMINE OXIME; OXIME; RADIOPHARMACEUTICAL AGENT;

AGED; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXIMES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 22144456781     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gauthier S, editor. Pharmacotherapy of Alzheimer's disease. London: Martín Dunitz, 1998.
2. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-53.
3. Defebvre UP, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999;40:956-62.
4. Jagust W, Chui H, Lee A-Y. Functional imaging in dementia. En: Qizilbash N, Schneider LS, Chui H, Tariot P, Brodaty H, Kaye J, Erkinjuntti T, editors. Evidence-based dementia practice. Oxford: Blackwell, 2003; p. 162-70.
5. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701-35.
6. Renshaw PF, Levin JM, Kaufman MJ, Ross MH, Lewis RF, Harris GJ. Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: present utility and future promise. Eur Radiol 1997;4(Suppl. 5):216-21.
7. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. Am J Neuroradiol 1998;19:l727-32.
8. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. Am J Neuroradiol 2001;22:1030-6.
9. 99mTc HMPAO SPECT. Acad Radiol 2002;9:1383-7.
10. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-30.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
12. Bouchard RW, Rossor MN. Typical clinical features. En: Gauthier S, editor. Clinical diagnosis and management of Alzheimer's disease. Second edition revised. London: Martin Dunitz, 2001; p. 57-71.
13. Reisberg B, Ferris SH, de León MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-9.
14. Rosen WG, Terry RD, FuId PA, Katzman R, Peck A. Pathologic verification of ischemia score in differentiation of dementias. Ann Neurol 1980;7:486-8.
15. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, (and 19 more authors), for the consortium on dementia with Lewy Bodies. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
16. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
17. Argimon JM, Jiménez J. Diseño de estudios descriptivos (III). Estudios sobre fiabilidad de una medida. Diseño y validación de cuestionarios. Unidad didáctica 4. Espluges de Llobregat: Signo, 1998.
18. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:1182-87.
20. George AE, Cha S. What role does functional MR imaging play in the diagnosis or prediction of future-onset Alzheimer's disease? Am J Neuroradiol 2001;22:1017-8.
21. Olazarán FJ, Álvarez-Linera J, Benito-León J. Utilidad de la perfusion por resonancia magnética y de la espectroscopia combinadas en un caso de demencia frontotemporal. Neurología 2002;17:53-7.